citral has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X; Shen, Y; Sun, Z | 1 |
1 other study(ies) available for citral and Lung Injury, Acute
| Article | Year |
|---|---|
Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Topics: Acute Lung Injury; Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Survival; Cytokines; Lipopolysaccharides; Lung; Macrophages, Alveolar; Male; Mice; Monoterpenes; NF-kappa B; Organ Size; Peroxidase; PPAR gamma | 2015 |